|
IMRX Immuneering Corp 1790340 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-13,460,895.00 |
| Balance Sheet |
|
Current Assets
|
$161,409,158.00 |
|
Assets
|
$214,809,790.00 |
|
Current Liabilities
|
$4,974,250.00 |
|
Liabilities
|
$8,291,619.00 |
|
Equity
|
$206,518,171.00 |
|
Shares Out
|
64697000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-18,433,444.00 |
|
Investing Cash Flow
|
$-63,070,775.00 |
| Market Analysis |
Market Cap
|
$273,668,310.00 |
|
Price
|
$4.12 |
|
PB
|
5.78 |
|
EPS
|
-0.21 |
|
FCF
|
$-18,513,374.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:32 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:30 |
|
| Apr |
May |
Jun |
| 2026-03-06 |
-0.18 |
|
|
2026-05-15 |
-0.21 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.40 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.38 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IMRX documents filed with the SEC.
IMRX Filings
Clear
